Patexia Logo
Patexia Logo
Products
  • IP Intelligence Reports
  • Patexia Concierge
  • Patent Analyzer
  • Trademarks Analyzer
  • Litigation Analyzer
  • All Products
Services
  • Lateral Opportunities
  • Expert Witness
  • Research Studies
  • Strategic Partnership
  • All Services
IP Community
  • IP Community
  • IP Webinars
  • In the News
Company
  • About Us
  • Press Release
  • Careers
  • Contact Us
Login
JoinBook a Meeting
Patexia Logo
Products
  • IP Intelligence Reports
  • Patexia Concierge
  • Patent Analyzer
  • Trademarks Analyzer
  • Litigation Analyzer
Services
  • Lateral Opportunities
  • Expert Witness
  • Research Studies
  • Strategic Partnership
Company
  • About Us
  • Press Release
  • Careers
  • Contact Us
Resources
  • IP Community
  • IP Webinars
  • In the News
  • Help Center
Contact
  • (310) 909-7611
  • 100 Wilshire Blvd. Suite 700
    Santa Monica, CA 90401 USA
  • info@patexia.com
  • Send a message
Follow Us
Terms and Conditions|Privacy Policy
© 2010-2023 Patexia Inc. All Rights Reserved.
Back to All Articles
Browse articles with tag: Drug Prices
You must be logged in to create a new article
All Articles
Pedram Sameni
Jul 25, 2024
•
ANDA Litigation
Patexia Insight 213: The Revlimid Dispute From Antitrust Battles to Patent Litigation
Revlimid (lenalidomide), developed by Celgene Corporation, has been a groundbreaking treatment for multiple myeloma, myelodysplastic syndromes, and mantle cell lymphoma... Read More
Joseph Allen
Oct 25, 2016
Winning the Drug Development Debate
The stage is being set for a coordinated attack on the patent system under the guise of making international health... Read More
Patexia Insight 228: Patent Litigation on the Rise in 2024
Pedram Sameni
Jan 9, 2025
•
Patent Litigation
Patexia Insight 228: Patent Litigation on the Rise in 2024
The year 2024 has seen an uptick in patent litigation, reversing the downward trend observed since 2022. This increase underscores... Read More
Intra-Cellular Therapies Surges 15% Following Settlement of Caplyta ANDA Litigation with Sandoz
Mikele Bicolli
5 days ago
•
ANDA Litigation
Intra-Cellular Therapies Surges 15% Following Settlement of Caplyta ANDA Litigation with Sandoz
Shares of Intra-Cellular Therapies (NASDAQ: ITCI) increased by nearly 15% last week after the company reached a significant settlement with... Read More
Patexia Insight 228: Patent Litigation on the Rise in 2024
Pedram Sameni
Jan 9, 2025
•
Patent Litigation
Patexia Insight 228: Patent Litigation on the Rise in 2024
The year 2024 has seen an uptick in patent litigation, reversing the downward trend observed since 2022. This increase underscores... Read More
Intra-Cellular Therapies Surges 15% Following Settlement of Caplyta ANDA Litigation with Sandoz
Mikele Bicolli
5 days ago
•
ANDA Litigation
Intra-Cellular Therapies Surges 15% Following Settlement of Caplyta ANDA Litigation with Sandoz
Shares of Intra-Cellular Therapies (NASDAQ: ITCI) increased by nearly 15% last week after the company reached a significant settlement with... Read More
Patexia Insight 228: Patent Litigation on the Rise in 2024
Pedram Sameni
Jan 9, 2025
•
Patent Litigation
Patexia Insight 228: Patent Litigation on the Rise in 2024
The year 2024 has seen an uptick in patent litigation, reversing the downward trend observed since 2022. This increase underscores... Read More
Featured